Rosemary extracts to receive antioxidant status.

• Upcoming Trade-Shows:
FI Asia, CPhl, HI Japan, Supply Side West, HI Europe,...

©Naturex 2008
Investors > Financial Informations > Key Figures
Key Figures Share Price Events Analysts Documents


Development of sales 2006
Distribution of sales by activity 2006
Distribution of sales by geographical area 2006
Simplified Profit and Lost 2006 - IFRS
Simplified balance sheet 2006 - IFRS





















Development of sales 2006




Back to Top

























Distribution of sales by activity 2006



Back to Top
























Distribution of sales by geographical area 2006



Back to Top

























Simplified Profit & Lost 2006 - IFRS

€M 31/12/2005* 31/12/2006 Variation Pro forma**



06/05 31/12/2006
Sales 50,1 66,2 + 31,9% 73,8
Cost of Sales 30,9 43,3 + 40,4% 48,4
% of sales 61,8% 66,3%
66,4%
Operating income 6,5 6,8 + 4,3% 6,7
% of sales 13,0% 10,3%
9,1%
Net income 4,0 5,6 + 40,4% 5,1
% of sales 8,0% 8,5%
6,9%
Group net income 3,9 5,6 + 41,6% 5,1
% of sales 7,9% 8,5%   6,9%

*Including Hammer Pharma 12 months



Back to Top





















Simplified balance sheet 2006 - IFRS

ASSETS   LIABILITIES
€M
31/12
2005 2006 2006*
Pro forma
  €M
31/12
2005 2006 2006*
Pro forma
Net fixed assets 46,4 46,4 53,9   Shareholder's equity 37,2 52,5 52,0
Inventories 23,9 29,8 32,6   Provisions 40,2 38,7 48,6
Clients 0,1 0,3 0,3   Financial debt 0,8 0,6 0,6
Other receivables 13,1 15,4 17,3   Deffered Taxes 9,7 10,6 12,8
Cash assets 4,4 10,5 10,6   Other debt - - 0,7
Total assets 87,9 102,4 114,7   Total liabilities 87,9 102,4 114,7

€M
31/12
2005 2006 2006*
Pro forma
Shareholder's equity 37,3 52,5 52,0
Net financial debt 35,8 28,1 38,0
Gearing 96,0% 53,5% 73,1%

*Including Hammer Pharma 12 months



Back to Top